HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Warren P Mason Selected Research

Oral Administration

11/2016Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Warren P Mason Research Topics

Disease

34Glioblastoma (Glioblastoma Multiforme)
01/2022 - 03/2005
22Glioma (Gliomas)
10/2022 - 02/2005
21Neoplasms (Cancer)
05/2022 - 08/2002
10Oligodendroglioma
05/2022 - 02/2005
6Astrocytoma (Pilocytic Astrocytoma)
01/2022 - 02/2005
5Brain Neoplasms (Brain Tumor)
10/2020 - 07/2005
4Disease Progression
01/2022 - 08/2002
2Necrosis
05/2022 - 06/2012
2Neoplasm Metastasis (Metastasis)
10/2020 - 03/2009
2Medulloblastoma
10/2020 - 05/2011
2Seizures (Absence Seizure)
08/2020 - 03/2014
2Melanoma (Melanoma, Malignant)
05/2020 - 12/2015
2Fatigue
11/2016 - 07/2012
2Diarrhea
09/2015 - 07/2012
2Encephalitis (Encephalitis, Rasmussen)
03/2014 - 01/2014
2Lymphoma (Lymphomas)
11/2003 - 08/2003
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
10/2022
1Edema (Dropsy)
05/2022
1Glomus Tumor (Glomus Tumors)
03/2022
1Neurofibromatosis 1 (Neurofibromatosis Type I)
03/2022
1Central Nervous System Neoplasms
01/2022
1Lymphopenia (Lymphocytopenia)
01/2021
1Glycogen Storage Disease Type VI (Glycogenosis Type VI)
10/2020
1Multiple Myeloma
10/2020
1Hematologic Neoplasms (Hematological Malignancy)
10/2020
1Epilepsy (Aura)
08/2020
1Guillain-Barre Syndrome
05/2020
1Residual Neoplasm
01/2018
1HIV Infections (HIV Infection)
11/2016
1Chronic Hepatitis B
11/2016
1Infections
11/2016
1Virus Diseases (Viral Diseases)
11/2016
1Death (Near-Death Experience)
01/2016
1Thrombocytopenia (Thrombopenia)
01/2016
1Thrombosis (Thrombus)
01/2016
1Demyelinating Diseases (Demyelinating Disease)
12/2015
1Hypersensitivity (Allergy)
09/2015
1Venous Thromboembolism
09/2015
1Drug Resistant Epilepsy
04/2014
1Status Epilepticus (Complex Partial Status Epilepticus)
03/2014
1Nausea
07/2012
1Vomiting
07/2012
1Myoclonus (Nocturnal Myoclonus)
10/2009
1Laryngismus (Laryngospasm)
10/2009
1Cerebellar Ataxia (Dysmetria)
10/2009
1Ataxia (Dyssynergia)
10/2009

Drug/Important Bio-Agent (IBA)

35Temozolomide (Temodar)FDA LinkGeneric
10/2022 - 03/2005
6Bevacizumab (Avastin)FDA Link
05/2022 - 05/2015
5Pharmaceutical PreparationsIBA
10/2020 - 07/2005
3Biomarkers (Surrogate Marker)IBA
01/2021 - 07/2013
3MethyltransferasesIBA
10/2018 - 02/2006
3Lomustine (CCNU)FDA Link
05/2017 - 06/2013
3Vincristine (Oncovin)FDA LinkGeneric
05/2017 - 06/2013
3Procarbazine (Matulane)FDA Link
05/2017 - 06/2013
3Alkylating AgentsIBA
06/2010 - 07/2005
2trametinibIBA
03/2022 - 01/2022
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2022 - 06/2013
2Monoclonal AntibodiesIBA
12/2015 - 07/2008
2EnzymesIBA
09/2015 - 12/2012
2Angiogenesis InhibitorsIBA
05/2015 - 05/2012
2ErbB Receptors (EGF Receptor)IBA
03/2015 - 02/2006
2DNA (Deoxyribonucleic Acid)IBA
01/2015 - 06/2010
2Anticonvulsants (Antiepileptic Drugs)IBA
04/2014 - 12/2012
2AntibodiesIBA
03/2014 - 10/2009
1GadoliniumIBA
05/2022
1SteroidsIBA
05/2022
1dabrafenibIBA
01/2022
1HhAntag691IBA
10/2020
1Bortezomib (Velcade)FDA Link
10/2020
1marizomibIBA
10/2020
1Proteasome Endopeptidase Complex (Proteasome)IBA
10/2020
1Proteasome InhibitorsIBA
10/2020
1cabozantinibIBA
01/2017
1CTLA-4 AntigenIBA
12/2015
1IpilimumabIBA
12/2015
1NivolumabIBA
12/2015
1PX-866IBA
09/2015
1CilengitideIBA
05/2015
1AfatinibIBA
03/2015
1epidermal growth factor receptor VIIIIBA
03/2015
1ChromatinIBA
01/2015
1AntigensIBA
03/2014
1O(6)-Methylguanine-DNA MethyltransferaseIBA
06/2013
1EverolimusFDA Link
12/2012
13- (4- ((4- chlorophenyl)sulfonyl)- 4- (2,5- difluorophenyl)cyclohexyl)propanoic acidIBA
07/2012
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
07/2012
1diazepinomicinIBA
04/2012
1GABA-A Receptors (GABA(A) Receptor)IBA
04/2012
1CationsIBA
10/2009
1AutoantibodiesIBA
10/2009

Therapy/Procedure

29Radiotherapy
01/2022 - 08/2002
26Drug Therapy (Chemotherapy)
01/2022 - 08/2002
20Therapeutics
10/2020 - 08/2002
3Chemoradiotherapy
10/2022 - 12/2005
1Conformal Radiotherapy
01/2021
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2021
1Cognitive Training
05/2019
1Oral Administration
11/2016
1Aftercare (After-Treatment)
12/2015
1Immunotherapy
12/2015